NYXH Nyxoah

Publication relating to transparency notifications

Publication relating to transparency notifications

                

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), September 5, 2025, 10:30 pm CET / 4:30 pm ET In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.

On September 4, 2025, Nyxoah received a transparency notification from Cochlear Limited and Cochlear Investments Pty Ltd following a passive crossing of a threshold. Based on the notification, Cochlear Investments Pty Ltd holds 5,631,319 voting rights, representing 14.999% of the total number of voting rights on August 29, 2025 (37,544,782).

The notification dated September 4, 2025 contains the following information:

  • Reason for the notification: passive crossing of a threshold
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Cochlear Limited (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
    • Cochlear Investments Pty Ltd (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
  • Date on which the threshold was crossed: August 29, 2025
  • Threshold that is crossed: 15%
  • Denominator: 37,544,782
  • Notified details:



A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
Cochlear Limited0000.00%0.00%
Cochlear Investments Pty Ltd3,947,6175,631,319015.00%0.00%
Subtotal3,947,6175,631,319  15.00% 
 TOTAL5,631,319 015.00%0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: Cochlear Investments Pty Ltd is a wholly owned subsidiary of Cochlear Limited, which is listed on the Australian Securities Exchange and has no controlling shareholder.
  • Additional information: This notification concerns a downward crossing of the 15% threshold following a passive decrease, whereby Cochlear Investments Pty Ltd’s holding in Nyxoah fell from 15.04% to 14.999% of the voting rights.

*

* *

Contact:

Nyxoah

John Landry, CFO



Attachment



EN
05/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contr...

Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc. Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgique – 15 septembre 2025, 22h10 CET / 16h10 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des alternatives thérapeutiques révolutionnaires pour l'apnée obstructive du sommeil (AOS) par la neuromodulation, a annoncé aujourd'hui avoir entamé une procédure judiciaire contre Inspire Medi...

 PRESS RELEASE

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Syste...

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc. (collectively, “Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that it has filed a lawsuit against Inspire Medical Systems, Inc. (“Inspire”) alleging that the Inspire IV and Inspire V device...

 PRESS RELEASE

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 5, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On September 4, 2025, Nyxoah received a transparency notification from Cochlear Limited and Cochlear Investments Pty Ltd following a passive crossing of a thresh...

 PRESS RELEASE

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence          INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 5 septembre 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu une notification de transparence comme détaillée ci-dessous. Le 4 septembre 2025, Nyxoah a reçu une notification de transparence de Cochlear Limited et Cochlear Investments Pty Ltd suite à un fr...

 PRESS RELEASE

Nyxoah Announces Upcoming Investor Events

Nyxoah Announces Upcoming Investor Events Nyxoah Announces Upcoming Investor Events Mont-Saint-Guibert, Belgium – September 2, 2025, 10:30pm CET / 4:30PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the following events during September: 2025 Wells Fargo Healthcare ConferenceSeptember 3rd – Boston, MA Cantor Global Healthcare Conference 2025 September 4th – New York, NYFireside Chat: 11:30-12...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch